Abstract
Disclosed are molecular diagnostic compositions and methods for predicting brain metastasis of breast cancer, as well as methods for drug repositioning to identify existing and new therapeutics for use in developing individualized, patient-specific treatment regimens for improving diagnoses and patient outcomes in individuals at risk for brain metastasis of breast cancer.
| Original language | English (US) |
|---|---|
| Patent number | US2012184560 |
| IPC | G01N 33/ 573 A I |
| Priority date | 9/26/11 |
| Filing date | 5/16/17 |
| State | Published - Jul 19 2012 |